- Home
- NSYS vs CLNN Comparison
NSYS vs CLNN Comparison
Compare NSYS & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSYS
- CLNN
- Stock Information
- Founded
- NSYS 1981
- CLNN 2012
- Country
- NSYS United States
- CLNN United States
- Employees
- NSYS N/A
- CLNN N/A
- Industry
- NSYS Industrial Machinery/Components
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- NSYS Technology
- CLNN Health Care
- Exchange
- NSYS Nasdaq
- CLNN Nasdaq
- Market Cap
- NSYS 22.3M
- CLNN 23.1M
- IPO Year
- NSYS N/A
- CLNN N/A
- Fundamental
- Price
- NSYS $9.06
- CLNN $5.35
- Analyst Decision
- NSYS
- CLNN Strong Buy
- Analyst Count
- NSYS 0
- CLNN 5
- Target Price
- NSYS N/A
- CLNN $33.00
- AVG Volume (30 Days)
- NSYS 5.2K
- CLNN 88.3K
- Earning Date
- NSYS 08-07-2025
- CLNN 08-14-2025
- Dividend Yield
- NSYS N/A
- CLNN N/A
- EPS Growth
- NSYS N/A
- CLNN N/A
- EPS
- NSYS N/A
- CLNN N/A
- Revenue
- NSYS $117,597,000.00
- CLNN $286,000.00
- Revenue This Year
- NSYS N/A
- CLNN N/A
- Revenue Next Year
- NSYS N/A
- CLNN $2,178.18
- P/E Ratio
- NSYS N/A
- CLNN N/A
- Revenue Growth
- NSYS N/A
- CLNN N/A
- 52 Week Low
- NSYS $7.25
- CLNN $2.28
- 52 Week High
- NSYS $13.90
- CLNN $6.90
- Technical
- Relative Strength Index (RSI)
- NSYS 56.89
- CLNN 70.45
- Support Level
- NSYS $8.05
- CLNN $5.12
- Resistance Level
- NSYS $9.74
- CLNN $5.60
- Average True Range (ATR)
- NSYS 0.24
- CLNN 0.48
- MACD
- NSYS 0.08
- CLNN 0.12
- Stochastic Oscillator
- NSYS 42.86
- CLNN 87.33
About NSYS Nortech Systems Incorporated
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.